NCT00065390View on ClinicalTrials.gov

Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

June 30, 2005

Conditions
Autoimmune DiseaseLymphatic DiseaseLymphoproliferative Disorder
Interventions
DRUG

Pyrimethamine

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00065390 - Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome | Biotech Hunter | Biotech Hunter